Recap: POINT Biopharma Global Q2 Earnings



POINT Biopharma Global PNT reported its Q2 earnings results on Friday, August 12, 2022 at 08:30 AM.

Here's what investors need to know about the announcement.


POINT Biopharma Global missed estimated earnings by 22.73%, reporting an EPS of $-0.27 versus an estimate of $-0.22.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 3.02% increase in the share price the next day.


Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for POINT Biopharma Global visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!